SCHEMBL4340261

SCHEMBL4340261

CC(Cc1cccc(OCCOc2ccc(C(C)C)cc2)c1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.53
FFAR1 O14842 3/20 0.49
PPARA Q07869 4/20 0.46
PPARG P37231 4/20 0.46
PPARD Q03181 3/20 0.46
PTGES O14684 1/20 0.46
ALOX5 P09917 1/20 0.46
LMNA P02545 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RXRA P19793 1/20 0.45
RXRB P28702 1/20 0.45
CYSLTR2 Q9NS75 1/20 0.44
CYSLTR1 Q9Y271 1/20 0.44
MAPK1 P28482 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4332472 0.86 MRGPRX4 (0.50) MRGPRX4PPARAPPARGPPARDPTGES
SCHEMBL4328603 0.85 PPARG (0.51) MRGPRX4PPARAPPARGPPARDPTGES
SCHEMBL4337921 0.85 KMT2A (0.52) FFAR1PPARAPPARGPPARDLMNA
SCHEMBL4348542 0.84 PPARA (0.60) MRGPRX4PPARAPPARGPPARD
SCHEMBL4347068 0.84 MRGPRX4 (0.50) MRGPRX4FFAR1PPARAPPARGPPARD
SCHEMBL4336229 0.81 MRGPRX4 (0.46) MRGPRX4FFAR1PPARAPPARGPPARD
SCHEMBL4332211 0.81 PPARA (0.53) MRGPRX4FFAR1PPARAPPARGPPARD
SCHEMBL4336529 0.80 MRGPRX4 (0.46) MRGPRX4FFAR1PPARAPPARGPPARD
SCHEMBL20905595 0.80 MME (0.59) FFAR1PPARAPPARGPTGESSMN1; SMN2
SCHEMBL28560495 0.80 FFAR1 (0.52) MRGPRX4FFAR1PPARAPPARGLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 MRGPRX4 428/4885FFAR1 17/4885PPARA 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.